Your browser doesn't support javascript.
loading
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms.
Neill, Erica; Rossell, Susan L; Yolland, Caitlin; Meyer, Denny; Galletly, Cherrie; Harris, Anthony; Siskind, Dan; Berk, Michael; Bozaoglu, Kiymet; Dark, Frances; Dean, Olivia M; Francis, Paul S; Liu, Dennis; Phillipou, Andrea; Sarris, Jerome; Castle, David J.
Afiliación
  • Neill E; Centre for Mental Health, Faculty of Health, Arts & Design, Swinburne University of Technology, Melbourne, Australia.
  • Rossell SL; Department of Mental Health, St Vincent's Hospital, Melbourne, Australia.
  • Yolland C; Department of Psychiatry, University of Melbourne, Melbourne, Australia.
  • Meyer D; Centre for Mental Health, Faculty of Health, Arts & Design, Swinburne University of Technology, Melbourne, Australia.
  • Galletly C; Department of Mental Health, St Vincent's Hospital, Melbourne, Australia.
  • Harris A; Centre for Mental Health, Faculty of Health, Arts & Design, Swinburne University of Technology, Melbourne, Australia.
  • Siskind D; Department of Mental Health, St Vincent's Hospital, Melbourne, Australia.
  • Berk M; Centre for Mental Health, Faculty of Health, Arts & Design, Swinburne University of Technology, Melbourne, Australia.
  • Bozaoglu K; Department of Psychiatry, Adelaide Medical School, University of Adelaide, Adelaide, Australia.
  • Dark F; Ramsay Health Care (SA) Mental Health, Adelaide, Australia.
  • Dean OM; Northern Adelaide Local Health Network, Adelaide, Australia.
  • Francis PS; Specialty of Psychiatry, Sydney Medical School, University of Sydney, Sydney, Australia.
  • Liu D; Westmead Institute for Medical Research, Westmead, NSW 2145, Australia.
  • Phillipou A; Metro South Addiction and Mental Health Service, Brisbane, Australia.
  • Sarris J; UQ School of Clinical Medicine, Brisbane, Australia.
  • Castle DJ; Deakin University, IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.
Schizophr Bull ; 48(6): 1263-1272, 2022 11 18.
Article en En | MEDLINE | ID: mdl-35857752
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Schizophr Bull Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Schizophr Bull Año: 2022 Tipo del documento: Article País de afiliación: Australia